[
AstraZeneca’s Ultomiris misses primary endpoint in adult HSCT-TMA trial
[og_img]
https://www.investing.com/news/company-news/astrazenecas-ultomiris-misses-primary-endpoint-in-adult-hscttma-trial-93CH-4813036
Investing.com
AstraZeneca’s Ultomiris misses primary endpoint in adult HSCT-TMA trial
Related articles




